Palti Yoram

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
62
Insider Sells Sum
$32.51M

Insider Activity of Palti Yoram

The largest sale of all time was on 2018-06-14 and amounted to 60000 shares of NovoCure Limited for $1.9M.

Biography of Palti Yoram

No biography is available at this moment.

2018-08-28SaleNovoCure Limited
NVCR
Chief Technology Officer
8,668
0.0093%
$40.27$349,098+21.39%
2018-08-27SaleNovoCure Limited
NVCR
Chief Technology Officer
26,900
0.029%
$40.05$1.08M+21.63%
2018-08-24SaleNovoCure Limited
NVCR
Chief Technology Officer
24,432
0.0263%
$40.00$977,290+20.91%
2018-07-16SaleNovoCure Limited
NVCR
Chief Technology Officer
30,000
0.0319%
$35.08$1.05M+30.35%
2018-06-15SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0661%
$31.09$1.87M+45.5%
2018-06-14SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0657%
$31.64$1.9M+42.02%
2018-04-26SaleNovoCure Limited
NVCR
Chief Technology Officer
41,932
0.0452%
$26.09$1.09M+39.06%
2018-04-24SaleNovoCure Limited
NVCR
Chief Technology Officer
11,200
0.0126%
$25.06$280,640+50.27%
2018-04-23SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0657%
$25.07$1.5M+45.91%
2018-04-20SaleNovoCure Limited
NVCR
Chief Technology Officer
38,724
0.0431%
$25.06$970,365+48.17%
2018-04-19SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0655%
$24.93$1.5M+46%
2018-04-18SaleNovoCure Limited
NVCR
Chief Technology Officer
28,144
0.0312%
$24.10$678,161+53.36%
2018-04-17SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0662%
$23.44$1.41M+56.56%
2018-04-04SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0642%
$19.89$1.19M+74.05%
2018-04-03SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.066%
$20.19$1.21M+76%
2018-04-02SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0661%
$20.46$1.23M+73.59%
2018-03-29SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0663%
$21.67$1.3M+61.38%
2017-11-13SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0674%
$17.13$1.03M+73.31%
2017-11-10SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0683%
$17.61$1.06M+69.36%
2017-11-09SaleNovoCure Limited
NVCR
Chief Technology Officer
60,000
0.0667%
$18.25$1.09M+59.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.